BALA CYNWYD, Pa., July 10, 2013 /PRNewswire/ -- Law Office of Brodsky & Smith, LLC announces that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all those investors who purchased or otherwise acquired shares of Amyris, Inc. (Nasdaq: AMRS) ("Amyris" or the "Company") between April 29, 2011 and February 8, 2012, inclusive (the "Class Period").
Click here to learn more about the investigation http://brodsky-smith.com/611-amrs-amyris-inc.html, or call 877-534-2690. There is no cost or obligation to you.
The Complaint alleges that the defendants made materially false and misleading statements concerning the Company's ability to produce Biofene. On November 1, 2011, Amyris disclosed that it would not be able to produce Biofene in the quantities previously represented. In reaction to this news, shares of Amyris fell more than 20% to close at $15.47 per share. Thereafter, on February 9, 2012, Amyris reported a second issue with Biofene production and the need to raise funds. This resulted in shares of Amyris falling to $6.99 per share.
If you are a member of the class described above, you may, not later than July 15, 2013, move the Court to serve as a lead plaintiff of the class, if you so choose. If you purchased shares of Amyris stock during the Class Period and wish to discuss this action, you may e-mail or call the Law Office of Brodsky & Smith, LLC who will, without obligation or cost to you, answer your questions. Please contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com, by visiting http://brodsky-smith.com/611-amrs-amyris-inc.html, or calling toll free 877-LEGAL-90.Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts